Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3635-3650
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3635
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3635
Table 5 Binding information for curcumin and docking of the hub target molecules
Hub targets | Binding energy (kcal/mol) | Hydrogen bonds | Hydrogen bonds, lengths | ||||||
ESR1 | -6.3 | Ala307 (A) | Gly366 (A) | Ser305 (A) | 2.82Å | 3.06Å | 2.95Å | 3.47Å | |
EGFR | -7.8 | Lys745 (A) | 3.31Å | ||||||
CYP3A4 | -8.4 | - | - | ||||||
MAPK14 | -7.9 | Lys53 (A) | 3.22Å | ||||||
CYP1A2 | -9.5 | Arg108 (A) | Arg456 (A) | 3.15Å | 3.15Å | ||||
CYP2B6 | -9.3 | Arg98 (A) | 2.95Å | 2.96Å |
- Citation: Yang PH, Wei YN, Xiao BJ, Li SY, Li XL, Yang LJ, Pan HF, Chen GX. Curcumin for gastric cancer: Mechanism prediction via network pharmacology, docking, and in vitro experiments. World J Gastrointest Oncol 2024; 16(8): 3635-3650
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3635.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3635